HomeABUS • NASDAQ
add
Arbutus Biopharma Corp
Previous close
$4.14
Day range
$4.09 - $4.19
Year range
$2.71 - $5.10
Market cap
794.30M USD
Avg Volume
1.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
About
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Founded
2007
Headquarters
Website
Employees
44